• Explore /
  • Poster
  • / The impact of relative dose intensity on overall and progression-free survival during cabozantinib therapy for unresectable hepatocellular carcinoma.

The impact of relative dose intensity on overall and progression-free survival during cabozantinib therapy for unresectable hepatocellular carcinoma.

Abstract Poster

Authors

null

Tsubasa Nobusawa

Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan;

Tsubasa Nobusawa , Kaoru Tsuchiya , Yutaka Yasui , Naoki Uchihara , Keito Suzuki , Yuki Tanaka , Haruka Miyamoto , Shun Ishido , Michiko Yamada , Taisei Keitoku , Hiroaki Matsumoto , Mayu Higuchi , Kenta Takaura , Shohei Tanaka , Chiaki Maeyashiki , Nobuharu Tamaki , Hiroyuki Nakanishi , Masayuki Kurosaki , Namiki Izumi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 569)

DOI

10.1200/JCO.2023.41.4_suppl.569

Abstract #

569

Poster Bd #

E1

Abstract Disclosures

Similar Posters

First Author: Changhoon Yoo

First Author: Kazuomi Ueshima

First Author: Jay Parekh

First Author: Keito Suzuki